Abstract
Rheumatoid arthritis (RA) is associated with increased mortality due to cardiovascular disease (CVD). Abnormalities in coagulation have been linked with CVD in general and RA population. The aim of our study is to determine whether particular single nucleotide polymorphisms thought to be involved in the regulation of coagulation are over-represented in patients with RA compared to controls. We compared the frequency of atherothrombotic polymorphisms (Factor V Leiden, fibrinogen G455A, prothrombin G20210A and plasminogen activator inhibitor 4G5G) in 322 RA patients [231 females, mean age 61.5 ± 12, median disease duration 10 years (IQR = 14)] with 441 local controls. No significant differences were observed in genotype or allele frequencies either between RA and controls or between the disease subgroups studied. Whereas these polymorphisms may be of importance at the level of individual patients, they are unlikely to be clinically important on a population basis.
References
Juhan-Vague I, Morange P, Christine Alessi M (1999) Fibrinolytic function and coronary risk. Curr Cardiol Rep 1:119–124
Wållberg-Jonsson S, Cederfelt M, Rantapää Dahlqvist S (2000) Hemostatic factors and cardiovascular disease in active rheumatoid arthritis: an 8 year followup study. J Rheumatol 27:71–75
Ye Z, Liu EH, Higgins JP, Keavney BD, Lowe GD, Collins R, Danesh J (2006) Seven haemostatic gene polymorphisms in coronary disease: meta-analysis of 66,155 cases and 91,307 controls. Lancet 367:651–658
Iacoviello L, Burzotta F, Di Castelnuovo A, Zito F, Marchioli R, Donati M (1998) The 4G/5G polymorphism of the PAI-1-1 promoter gene and the risk of myocardial infarction: a meta-analysis. Thromb Haemost 80:1029–1030
Green FR, Hamsten A, Blomback M (1993) The role of the fibrinogen genotype in determining plasma fibrinogen levels in the young survivors of myocardial infarction and healthy controls from Sweden. Thromb Haemost 70:915–920
Arlestig L, Wållberg Jonsson S, Stegmayr B, Rantapää-Dahlqvist S (2007) Polymorphism of genes related to cardiovascular disease in patients with rheumatoid arthritis. Clin Exp Rheumatol 25:866–871
Torres-Carrillo N, Torres-Carrillo NM, Martínez-Bonilla GE, Vázquez-Del Mercado M, Palafox-Sánchez CA, Oregón-Romero E, Bernard-Medina AG, Rangel-Villalobos H, Muñoz-Valle JF (2009) Plasminogen activator inhibitor-1 C/G polymorphism in relation to plasma levels in rheumatoid arthritis. Clin Exp Med 9:223–228
Arnett FC, Edwarthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324
Subrungruang I, Mungthin M, Chavalitshewinkoon-Petmitr P, Rangsin R, Naaglor T, Leelayoova S (2004) Evaluation of DNA extraction and PCR methods for detection of Enterocytozoon bieneusi in stool. J Clin Microbiol 42:3490–3494
Panoulas VF, Douglas KM, Smith JP, Metsios GS, Elisaf MS, Nightingale P, Kitas GD (2009) Galectin-2 (LGALS2) 3279C/T polymorphism may be independently associated with diastolic blood pressure in patients with rheumatoid arthritis. Clin Exp Hypertens 31:93–104
Douglas KMJ, Pace AV, Treharne GJ, Saratzis A, Nightingale P, Erb N, Banks MJ, Kitas GD (2005) Excess recurrent cardiac events in rheumatoid arthritis patients with acute coronary syndrome. Ann Rheum Dis 65:348–353
Torres-Carrillo N, Magdalena Torres-Carrillo N, Vázquez-Del Mercado M, Rangel-Villalobos H, Parra-Rojas I, Sánchez-Enríquez S, Francisco Muñoz-Valle J (2008) Distribution of –844 G/A and Hind III C/G PAI-1 polymorphisms and plasma PAI-1 levels in Mexican subjects: comparison of frequencies between populations. Clin Appl Thromb Hemost 14:220–226
Goodson NJ, Wiles NJ, Lunt M, Barrett EM, Silman AJ, Symmons DP (2002) Mortality in early inflammatory polyarthritis: cardiovascular mortality is increased in seropositive patients. Arthritis Rheum 48:2010–2019
Turesson C, McClelland RL, Christianson TJ, Matteson EL (2006) Multiple extra-articular manifestations are associated with poor survival in patients with rheumatoid arthritis. Ann Rheum Dis 65:1533–1534
Lane DA, Grant PJ (2000) Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease. Blood 95:1517–1532
Acknowledgments
Dr Theodoros Dimitroulas has been supported by the Rheumatology Society of Northern Greece and the Hellenic Society for Rheumatology.
Author information
Authors and Affiliations
Corresponding author
Additional information
The authors Theodoros Dimitroulas and Karen M. J. Douglas have equally contributed to this work and therefore share first authorship.
Rights and permissions
About this article
Cite this article
Dimitroulas, T., Douglas, K.M.J., Smith, J. et al. Lack of association between polymorphisms of thrombogenic genes and disease susceptibility in rheumatoid arthritis . Rheumatol Int 33, 2429–2432 (2013). https://doi.org/10.1007/s00296-012-2392-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-012-2392-6